Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
First-Year Experiences with the Interagency Guidelines for Drug Donations
(2000; 51 pages)
Table of Contents
View the documentAcknowledgements
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Sources of information and study methodology
Open this folder and view contents3. Dissemination and uptake of the Guidelines
Open this folder and view contents4. Basic characteristics of drug donations
Open this folder and view contents5. Practical benefits as a result of the Guidelines
View the document6. Drug donations which were hampered, delayed or cancelled
Open this folder and view contents7. Experiences and opinions regarding the 12-month shelf-life requirement
Open this folder and view contents8. Other suggestions to improve the Guidelines
Open this folder and view contents9. How could donation practice be further improved?
View the document10. Summary of recommendations
View the document11. Postscript
View the documentReferences
 

First-Year Experiences with the Interagency Guidelines for Drug Donations

WHO/EDM/PAR/2000.1
English only
Distribution: limited

Department of Essential Drugs and Medicines Policy
World Health Organization

Authors

Ms Radha Asher
Dr Robin Gray
Dr Hans Hogerzeil

Department of Essential Drugs and Medicines Policy
World Health Organization, Geneva

Quotation from an individual health institution:

We see the Guidelines as a help to us, to continue to provide essential services to as many patients as possible, and at reasonable cost. We also see the Guidelines as a necessary component in the development of a health care system that is sustainable, encouraging recipients and patients to take more responsibility in the management of health care delivery.

© World Health Organization 2000
________________________________________
This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO).
The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior permission of WHO.

The views expressed in documents by named authors are solely the responsibility of those authors.

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014